CLINICAL TRIALS PROFILE FOR APTIOM
✉ Email this page to a colleague
All Clinical Trials for aptiom
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT02912364 ↗ | Comparison of the Cognitive and Behavioral Effects of Eslicarbazepine Acetate and Carbamazepine in Healthy Adults | Completed | Sunovion | Phase 4 | 2016-07-01 | Double-blind, randomized, two period crossover comparison of the cognitive and behavioral effects of Eslicarbazepine acetate and Carbamazepine in healthy volunteers. |
NCT02912364 ↗ | Comparison of the Cognitive and Behavioral Effects of Eslicarbazepine Acetate and Carbamazepine in Healthy Adults | Completed | Stanford University | Phase 4 | 2016-07-01 | Double-blind, randomized, two period crossover comparison of the cognitive and behavioral effects of Eslicarbazepine acetate and Carbamazepine in healthy volunteers. |
NCT03108729 ↗ | A Pediatric Drug Study to Determine the Long-term Safety and Tolerability in Children and Adolescents (4-17 Years in Age) Taking the Drug | Withdrawn | Sunovion | Phase 3 | 2017-07-06 | A pediatric drug study to determine the long-term safety and tolerability in children and adolescents (4-17 years in age) taking the drug (elsicarbazepine acetate) |
NCT03116828 ↗ | A Study of a Drug to be Used in Addition With Another Drug to Treat Adults With Uncontrolled Partial-onset Seizures | Completed | Sunovion | Phase 4 | 2017-07-07 | A study of a drug to be used in addition with another drug to treat adults with Uncontrolled Partial-onset Seizures |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for aptiom
Condition Name
Clinical Trial Locations for aptiom
Trials by Country
Clinical Trial Progress for aptiom
Clinical Trial Phase
Clinical Trial Sponsors for aptiom
Sponsor Name